These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3069099

  • 1. Phenotypic and genotypic variability of generalized peroxisomal disorders.
    Naidu S, Moser AE, Moser HW.
    Pediatr Neurol; 1988; 4(1):5-12. PubMed ID: 3069099
    [Abstract] [Full Text] [Related]

  • 2. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders.
    Slawecki ML, Dodt G, Steinberg S, Moser AB, Moser HW, Gould SJ.
    J Cell Sci; 1995 May; 108 ( Pt 5)():1817-29. PubMed ID: 7544797
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of branched chain fatty acids in peroxisomal disorders.
    Singh H, Usher S, Johnson D, Poulos A.
    J Inherit Metab Dis; 1990 May; 13(3):387-9. PubMed ID: 1700192
    [No Abstract] [Full Text] [Related]

  • 4. Peroxisomal disorders. Neurodevelopmental and biochemical aspects.
    Brown FR, Voigt R, Singh AK, Singh I.
    Am J Dis Child; 1993 Jun; 147(6):617-26. PubMed ID: 7685145
    [Abstract] [Full Text] [Related]

  • 5. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
    Poll-The BT, Skjeldal OH, Stokke O, Poulos A, Demaugre F, Saudubray JM.
    Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
    [Abstract] [Full Text] [Related]

  • 6. Peroxisomal disorders: clinical commentary and future prospects.
    Wilson GN, Holmes RD, Hajra AK.
    Am J Med Genet; 1988 Jul; 30(3):771-92. PubMed ID: 2461077
    [Abstract] [Full Text] [Related]

  • 7. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
    Molzer B, Kainz-Korschinsky M, Sundt-Heller R, Bernheimer H.
    J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
    [Abstract] [Full Text] [Related]

  • 8. Photosensitized killing of cultured fibroblasts from patients with peroxisomal disorders due to pyrene fatty acid-mediated ultraviolet damage.
    Hoefler G, Paschke E, Hoefler S, Moser AB, Moser HW.
    J Clin Invest; 1991 Dec; 88(6):1873-9. PubMed ID: 1752949
    [Abstract] [Full Text] [Related]

  • 9. Immunochemical and biochemical studies of fatty acid oxidation in fibroblasts of Zellweger and X-linked adrenoleukodystrophy patients.
    Reubsaet FA, Veerkamp JH, Brückwilder ML, Trijbels JM, Hashimoto T, Monnens LA.
    Biochim Biophys Acta; 1991 Jun 03; 1083(3):305-9. PubMed ID: 2049396
    [Abstract] [Full Text] [Related]

  • 10. Peroxisomal disorders.
    Moser HW, Bergin A, Cornblath D.
    Biochem Cell Biol; 1991 Jul 03; 69(7):463-74. PubMed ID: 1724376
    [Abstract] [Full Text] [Related]

  • 11. [Clinical biochemical and genetic aspects of peroxisome-deficient disorders].
    Suzuki Y.
    No To Hattatsu; 1992 Mar 03; 24(2):194-7. PubMed ID: 1373633
    [Abstract] [Full Text] [Related]

  • 12. Adrenoleukodystrophy and Zellweger syndrome.
    Moser HW, Moser AB, Chen WW, Watkins PA.
    Prog Clin Biol Res; 1990 Mar 03; 321():511-35. PubMed ID: 2183241
    [No Abstract] [Full Text] [Related]

  • 13. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients.
    Roscher AA, Hoefler S, Hoefler G, Paschke E, Paltauf F, Moser A, Moser H.
    Pediatr Res; 1989 Jul 03; 26(1):67-72. PubMed ID: 2475849
    [Abstract] [Full Text] [Related]

  • 14. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
    Van Veldhoven PP, Huang S, Eyssen HJ, Mannaerts GP.
    J Inherit Metab Dis; 1993 Jul 03; 16(2):381-91. PubMed ID: 7692128
    [Abstract] [Full Text] [Related]

  • 15. Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders.
    Martinez M.
    Brain Res; 1992 Jun 26; 583(1-2):171-82. PubMed ID: 1504825
    [Abstract] [Full Text] [Related]

  • 16. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
    Molzer B, Stöckler S, Bernheimer H.
    Wien Klin Wochenschr; 1992 Jun 26; 104(21):665-70. PubMed ID: 1282286
    [Abstract] [Full Text] [Related]

  • 17. Formation of a novel arachidonic acid metabolite in peroxisomes.
    Gordon JA, Heller SK, Rhead WJ, Watkins PA, Spector AA.
    Prostaglandins Leukot Essent Fatty Acids; 1995 Jun 26; 52(2-3):77-81. PubMed ID: 7540307
    [Abstract] [Full Text] [Related]

  • 18. [Peroxisomes and peroxisomal diseases].
    Petelenz M, Gonciarz Z, Grzybek H, Panz B.
    Postepy Hig Med Dosw; 1991 Jun 26; 45(1-2):77-99. PubMed ID: 1717967
    [Abstract] [Full Text] [Related]

  • 19. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata.
    Schutgens RB, Bouman IW, Nijenhuis AA, Wanders RJ, Frumau ME.
    Clin Chem; 1993 Aug 26; 39(8):1632-7. PubMed ID: 8353949
    [Abstract] [Full Text] [Related]

  • 20. Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy.
    Small GM, Santos MJ, Imanaka T, Poulos A, Danks DM, Moser HW, Lazarow PB.
    J Inherit Metab Dis; 1988 Aug 26; 11(4):358-71. PubMed ID: 2468817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.